What is the recommended tapering schedule when discontinuing duloxetine (Cymbalta) 120mg daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tapering Protocol for Duloxetine 120mg Daily

When discontinuing duloxetine 120mg daily, a gradual taper over 2-4 weeks is strongly recommended to minimize withdrawal symptoms and ensure patient safety.

Recommended Tapering Schedule

The optimal tapering schedule for duloxetine 120mg daily is:

  1. Week 1-2: Reduce from 120mg to 90mg daily
  2. Week 3-4: Reduce from 90mg to 60mg daily
  3. Week 5-6: Reduce from 60mg to 30mg daily
  4. Week 7-8: Discontinue completely

This gradual approach minimizes the risk of discontinuation syndrome, which can include dizziness, nausea, headache, paresthesia, irritability, and insomnia 1.

Rationale for Gradual Tapering

Duloxetine has a relatively short half-life (12 hours), making it particularly prone to causing withdrawal symptoms if discontinued abruptly. The Mayo Clinic Proceedings specifically recommends that "when discontinuing, duloxetine should be tapered over at least 2 to 4 weeks for those treated with therapy longer than 3 weeks" 2.

Monitoring During Tapering

  • Monitor for withdrawal symptoms at each dose reduction
  • Common withdrawal symptoms include:
    • Dizziness and lightheadedness
    • Nausea and vomiting
    • Headache
    • Irritability
    • Insomnia or vivid dreams
    • "Brain zaps" (electric shock-like sensations)
    • Anxiety and agitation

Special Considerations

  • Higher starting dose: Since you're starting at 120mg (the maximum recommended dose), the tapering process should be particularly gradual 1.
  • Duration of treatment: Patients who have been on duloxetine for longer periods (>8 weeks) may require a more extended tapering schedule 1.
  • Individual sensitivity: Some patients may require even more gradual tapering if they experience significant withdrawal symptoms at any stage 3.

Alternative Approaches

  • Extended tapering: For patients experiencing significant withdrawal symptoms, consider extending each step to 2 weeks or adding intermediate steps (e.g., 75mg, 45mg) 1.
  • Cross-tapering: If switching to another antidepressant, consider cross-tapering by gradually reducing duloxetine while introducing the new medication 1.

Cautions

  • Never discontinue abruptly: Abrupt discontinuation of duloxetine, especially at higher doses like 120mg daily, can lead to severe withdrawal symptoms 3.
  • Weekend planning: Consider timing dose reductions to coincide with weekends or days off work when possible, as initial adjustment symptoms may be more pronounced in the first few days after each reduction 1.
  • Medical supervision: All dose reductions should be performed under medical supervision, with the option to slow the taper if significant withdrawal symptoms occur 1.

By following this structured tapering approach, the risk of discontinuation syndrome can be significantly minimized while safely discontinuing duloxetine therapy.

References

Guideline

Management of Duloxetine for Depression and Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Adverse reactions to duloxetine in depression.

Expert opinion on drug safety, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.